Search for Clinical Trial Results
Gaucher Disease - 63 Studies Found
Status | Study |
Completed |
Study Name: A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE) Condition: Gaucher Disease Date: 2010-02-23 Interventions: Drug: Eliglustat tartrate Oral Capsule in 50 mg or 100 mg dosages |
Completed |
Study Name: Auto-antibodies Prevalence and CD1 Role in Gaucher Disease Condition: Gaucher Disease Date: 2016-01-05 Interventions: Genetic: genetic analyses |
Completed |
Study Name: A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease Condition: Gaucher Disease Date: 2011-08-22 Interventions: Drug: Taliglucerase alfa Taliglucerase infusion every two weeks for 21 months |
Completed |
Study Name: Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease Condition: Type 1 Gaucher Disease Date: 2006-04-26 Interventions: Drug: miglustat miglustat oral capsules 100mg three times daily (TID) |
Recruiting |
Study Name: SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease Condition: Gaucher Disease Date: 2015-09-09 |
Recruiting |
Study Name: Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1) Condition: Gaucher Disease Type 1 Date: 2015-08-21 Interventions: Drug: N-acetylcysteine 1800mg NAC twice daily (3600mg/day) orally for approximately 90 days. |
Completed |
Study Name: Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease Condition: Type 1 Gaucher Disease Date: 2006-04-26 Interventions: Drug: miglustat miglustat oral capsules 100mg three times daily (TID) |
Not yet recruiting |
Study Name: Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease Condition: Type 1 Gaucher Disease Date: 2016-09-23 Interventions: Drug: Elelyso 60 units/kg All patients receive Elelyso 60 units/kg. |
Completed |
Study Name: Comparison of BMD Measurement by DEXA to BeamMed Speed-of-Sound Measurement at Forearm in Patients With Gaucher Disease Condition: Gaucher Disease Type 1 Date: 2014-01-27 Interventions: Device: BeamMed Speed-of-Sound bone strength test at forearm BeamMed Speed-of-Sound bone strength test a |
Terminated |
Study Name: A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101 Condition: Type 1 Gaucher Disease Date: 2009-04-02 Interventions: Drug: AT2101 225mg (nine 25mg capsules total dose) to be taken by mouth every day for 9 days (Study Days |